52 results
Pharmacologic prophylaxis of VTE in selected clinical scenarios.

Enoxaparin 
Dalteparin 
Fondaparinux 
Dabigatran 
Unfractionated Heparin
Warfarin 
Aspirin 

#prophylaxis #VTE
VTE in selected clinical ... #DVT #dosing #Medications ... #management #indications ... #pharmacology #table
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Antianginal #Medications ... #Cardiology #Pharmacology ... #Management #Therapy ... #Table #Overview
Clinical Pharmacologic Properties of Antiarrhythmic Drugs

#Antiarrhythmic #Drugs #Medications #Pharmacology #Cardiology #Table #Effects
Clinical Pharmacologic ... Antiarrhythmic #Drugs #Medications ... #Pharmacology #Cardiology ... #Table #Effects
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Each class of medications ... summarizes the A1C ... pharmacotherapy #table ... #comparison #management ... #medications #diabetes
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
For most indications ... #management #algorithm ... pharmacology #treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
Osborn (J Wave)

Etiology 
• Hypothermia (below 320C / SOOF) 
• Normal variant 
• Hypercalcemia 
• Neurological
Normal variant • Hypercalcemia ... Neurological insult • Medications ... fibrillation Clinical ... #Differential #Cardiology
Medications for the Treatment of Hyperkalemia
The goals of acute treatment are to prevent potentially life-threatening cardiac
Medications for ... algorithm for the management ... , and Table 3 summarizes ... medications used ... #Management #Medications
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
and Management ... Etiology: • Medications ... clear cause) Management ... Elimination (see Table ... STOP offending medications
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... Pharm #EM #IM #Cardiology ... #Afib #Common #Medications
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
2017 ACC/AHA/HFSA ... Guideline for the Management ... American College of Cardiology ... Task Force on Clinical ... #HeartFailure #Management